These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 27124673)

  • 1. Phytochemicals as future drugs for Parkinson's disease: a comprehensive review.
    Shahpiri Z; Bahramsoltani R; Hosein Farzaei M; Farzaei F; Rahimi R
    Rev Neurosci; 2016 Aug; 27(6):651-68. PubMed ID: 27124673
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Natural Phytochemicals as Novel Therapeutic Strategies to Prevent and Treat Parkinson's Disease: Current Knowledge and Future Perspectives.
    Balakrishnan R; Azam S; Cho DY; Su-Kim I; Choi DK
    Oxid Med Cell Longev; 2021; 2021():6680935. PubMed ID: 34122727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biomarkers of Parkinson's disease: present and future.
    Miller DB; O'Callaghan JP
    Metabolism; 2015 Mar; 64(3 Suppl 1):S40-6. PubMed ID: 25510818
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic potential of the endoplasmic reticulum located and secreted CDNF/MANF family of neurotrophic factors in Parkinson's disease.
    Voutilainen MH; Arumäe U; Airavaara M; Saarma M
    FEBS Lett; 2015 Dec; 589(24 Pt A):3739-48. PubMed ID: 26450777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tea and Parkinson's disease: Constituents of tea synergize with antiparkinsonian drugs to provide better therapeutic benefits.
    Dutta D; Mohanakumar KP
    Neurochem Int; 2015 Oct; 89():181-90. PubMed ID: 26271432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phytochemical constituents as future antidepressants: a comprehensive review.
    Bahramsoltani R; Farzaei MH; Farahani MS; Rahimi R
    Rev Neurosci; 2015; 26(6):699-719. PubMed ID: 26146123
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Systematic Review of Plant-Derived Natural Compounds for Anxiety Disorders.
    Farzaei MH; Bahramsoltani R; Rahimi R; Abbasabadi F; Abdollahi M
    Curr Top Med Chem; 2016; 16(17):1924-42. PubMed ID: 26845556
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroprotective effects of piperine on the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinson's disease mouse model.
    Yang W; Chen YH; Liu H; Qu HD
    Int J Mol Med; 2015 Nov; 36(5):1369-76. PubMed ID: 26648012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acetylcorynoline attenuates dopaminergic neuron degeneration and α-synuclein aggregation in animal models of Parkinson's disease.
    Fu RH; Wang YC; Chen CS; Tsai RT; Liu SP; Chang WL; Lin HL; Lu CH; Wei JR; Wang ZW; Shyu WC; Lin SZ
    Neuropharmacology; 2014 Jul; 82():108-20. PubMed ID: 23973292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-apoptotic effect of modified Chunsimyeolda-tang, a traditional Korean herbal formula, on MPTP-induced neuronal cell death in a Parkinson's disease mouse model.
    Li H; Park G; Bae N; Kim J; Oh MS; Yang HO
    J Ethnopharmacol; 2015 Dec; 176():336-44. PubMed ID: 26593210
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of Parkinson's disease. Psychological disorders: striking a balance in order to optimise antiparkinsonian treatment.
    Prescrire Int; 2011 Oct; 20(120):242-5. PubMed ID: 21970092
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic potential of nerve growth factors in Parkinson's disease.
    Collier TJ; Sortwell CE
    Drugs Aging; 1999 Apr; 14(4):261-87. PubMed ID: 10319241
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Saxagliptin: a novel antiparkinsonian approach.
    Nassar NN; Al-Shorbagy MY; Arab HH; Abdallah DM
    Neuropharmacology; 2015 Feb; 89():308-17. PubMed ID: 25446674
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic effects of GM1 on Parkinson's disease in rats and its mechanism.
    Ba XH
    Int J Neurosci; 2016; 126(2):163-7. PubMed ID: 25495991
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New insight into the therapeutic role of the serotonergic system in Parkinson's disease.
    Ohno Y; Shimizu S; Tokudome K; Kunisawa N; Sasa M
    Prog Neurobiol; 2015 Nov; 134():104-21. PubMed ID: 26455457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of a phytopharmaceutical medicine, Ginko biloba extract 761, in an animal model of Parkinson's disease: therapeutic perspectives.
    Rojas P; Montes P; Rojas C; Serrano-García N; Rojas-Castañeda JC
    Nutrition; 2012; 28(11-12):1081-8. PubMed ID: 22817828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Shedding light into the role of BDNF in the pharmacotherapy of Parkinson's disease.
    Fumagalli F; Racagni G; Riva MA
    Pharmacogenomics J; 2006; 6(2):95-104. PubMed ID: 16402079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurotrophic factors for the treatment of Parkinson's disease.
    Sullivan AM; Toulouse A
    Cytokine Growth Factor Rev; 2011 Jun; 22(3):157-65. PubMed ID: 21689963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroprotective and Therapeutic Strategies against Parkinson's Disease: Recent Perspectives.
    Sarkar S; Raymick J; Imam S
    Int J Mol Sci; 2016 Jun; 17(6):. PubMed ID: 27338353
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The medical treatment of Parkinson disease from James Parkinson to George Cotzias.
    Fahn S
    Mov Disord; 2015 Jan; 30(1):4-18. PubMed ID: 25491387
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.